| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President And CEO | Chief Executive Officer
4 companies
Scangos George A is a Director at EXELIXIS, INC. with holdings across 4 companies. Recent SEC Form 4 filings include 0 buys and 23 sells.
Estimated insider holdings value: $53.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2025 | VIR Vir Biotechnology, Inc. | Director | Sell | 10,056 | $9.45 | $95,063.39 | -1.4% | -50.8% | +0.2% | |
| Feb 18, 2025 | VIR Vir Biotechnology, Inc. | Director | Sell | 10,964 | $9.81 | $107,575.48 | -1.5% | -52.1% | -19.2% | |
| Feb 26, 2024 | VIR Vir Biotechnology, Inc. | Director | Sell | 27,750 | $11.07 | $307,258.83 | -10.2% | -9.8% | -23.5% | |
| Feb 20, 2024 | VIR Vir Biotechnology, Inc. | Director | Sell | 27,750 | $10.23 | $283,770.97 | -8.5% | -5.3% | -3.7% | |
| Feb 24, 2023 | VIR Vir Biotechnology, Inc. | President And CEO | Sell | 27,750 | $24.53 | $680,747.27 | -5.0% | +12.1% | -49.9% | |
| Feb 21, 2023 | VIR Vir Biotechnology, Inc. | President And CEO | Sell | 27,750 | $27.23 | $755,517.40 | -4.3% | -4.6% | -62.5% | |
| Feb 18, 2022 | VIR Vir Biotechnology, Inc. | President And CEO | Sell | 27,750 | $31.11 | $863,378.01 | -10.2% | -17.3% | -14.6% | |
| May 18, 2020 | EXEL Exelixis, Inc. | Director | Sell | 75,000 | $25.96 | $1,947,000.00 | -9.5% | - | - | |
| Apr 24, 2020 | EXEL Exelixis, Inc. | Director | Sell | 115,000 | $26.02 | $2,992,235.00 | -4.8% | - | - | |
| Apr 22, 2020 | EXEL Exelixis, Inc. | Director | Sell | 60,000 | $24.08 | $1,445,079.00 | -1.4% | - | - |